Yield10 Bioscience, Inc. (YTEN)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -230 Thousand USD | -11.65% |
| 2022 | -206 Thousand USD | -672.22% |
| 2021 | 36 Thousand USD | 100.81% |
| 2020 | -4.42 Million USD | -9.38% |
| 2019 | -4.04 Million USD | 4.38% |
| 2018 | -4.22 Million USD | -15.71% |
| 2017 | -3.65 Million USD | 19.02% |
| 2016 | -4.51 Million USD | -333.25% |
| 2015 | 1.93 Million USD | 46.74% |
| 2014 | 1.31 Million USD | -44.34% |
| 2013 | 2.36 Million USD | -94.21% |
| 2012 | 40.89 Million USD | 277.63% |
| 2011 | -23.02 Million USD | 0.88% |
| 2010 | -23.22 Million USD | -0.78% |
| 2009 | -23.04 Million USD | 0.29% |
| 2008 | -23.11 Million USD | -26.86% |
| 2007 | -18.21 Million USD | -174.16% |
| 2006 | -6.64 Million USD | -107.7% |
| 2005 | -3.19 Million USD | -82.99% |
| 2004 | -1.74 Million USD | -173.36% |
| 2003 | 2.38 Million USD | 19.82% |
| 2002 | 1.98 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 450 Thousand USD | 50.0% |
| 2024 Q1 | 300 Thousand USD | 2407.69% |
| 2023 FY | -230 Thousand USD | -11.65% |
| 2023 Q2 | -82 Thousand USD | 27.43% |
| 2023 Q4 | -13 Thousand USD | 81.94% |
| 2023 Q1 | -113 Thousand USD | -39.51% |
| 2023 Q3 | -72 Thousand USD | 12.2% |
| 2022 Q2 | -1.91 Million USD | -38160.0% |
| 2022 FY | -206 Thousand USD | -672.22% |
| 2022 Q3 | -57 Thousand USD | 97.02% |
| 2022 Q4 | -81 Thousand USD | -42.11% |
| 2022 Q1 | -5000.00 USD | -225.0% |
| 2021 FY | 36 Thousand USD | 100.81% |
| 2021 Q2 | -1.47 Million USD | -31.88% |
| 2021 Q1 | -1.12 Million USD | -3.13% |
| 2021 Q3 | -1.54 Million USD | -4.54% |
| 2021 Q4 | 4000.00 USD | 100.26% |
| 2020 FY | -4.42 Million USD | -9.38% |
| 2020 Q1 | -1.28 Million USD | -20.62% |
| 2020 Q2 | -958 Thousand USD | 25.21% |
| 2020 Q3 | -1.09 Million USD | -14.41% |
| 2020 Q4 | -1.08 Million USD | 0.91% |
| 2019 FY | -4.04 Million USD | 4.38% |
| 2019 Q1 | -1.09 Million USD | -15.44% |
| 2019 Q2 | -873 Thousand USD | 20.56% |
| 2019 Q3 | -1 Million USD | -15.46% |
| 2019 Q4 | -1.06 Million USD | -5.36% |
| 2018 FY | -4.22 Million USD | -15.71% |
| 2018 Q3 | -1.25 Million USD | -29.13% |
| 2018 Q4 | -952 Thousand USD | 24.38% |
| 2018 Q1 | -1.04 Million USD | 6.55% |
| 2018 Q2 | -975 Thousand USD | 6.34% |
| 2017 Q4 | -1.11 Million USD | -22.55% |
| 2017 FY | -3.65 Million USD | 19.02% |
| 2017 Q3 | -909 Thousand USD | -7.57% |
| 2017 Q2 | -845 Thousand USD | -7.64% |
| 2017 Q1 | -785 Thousand USD | -862.14% |
| 2016 FY | -4.51 Million USD | -333.25% |
| 2016 Q4 | 103 Thousand USD | 109.59% |
| 2016 Q3 | -1.07 Million USD | -140.19% |
| 2016 Q2 | 2.67 Million USD | 378.85% |
| 2016 Q1 | 558 Thousand USD | 56.3% |
| 2015 Q1 | 561 Thousand USD | -24.8% |
| 2015 Q4 | 357 Thousand USD | -1.38% |
| 2015 Q3 | 362 Thousand USD | -44.65% |
| 2015 Q2 | 654 Thousand USD | 16.58% |
| 2015 FY | 1.93 Million USD | 46.74% |
| 2014 Q4 | 746 Thousand USD | 584.42% |
| 2014 FY | 1.31 Million USD | -44.34% |
| 2014 Q1 | 374 Thousand USD | 392.11% |
| 2014 Q2 | 396 Thousand USD | 5.88% |
| 2014 Q3 | -154 Thousand USD | -138.89% |
| 2013 Q1 | 1.38 Million USD | 77.92% |
| 2013 Q2 | 510 Thousand USD | -63.2% |
| 2013 FY | 2.36 Million USD | -94.21% |
| 2013 Q3 | 396 Thousand USD | -22.35% |
| 2013 Q4 | 76 Thousand USD | -80.81% |
| 2012 Q2 | 486 Thousand USD | -98.54% |
| 2012 FY | 40.89 Million USD | 277.63% |
| 2012 Q4 | 779 Thousand USD | 117.6% |
| 2012 Q3 | 358 Thousand USD | -26.34% |
| 2012 Q1 | 33.22 Million USD | 687.58% |
| 2011 Q2 | -5.8 Million USD | 1.09% |
| 2011 Q1 | -5.87 Million USD | -3.98% |
| 2011 Q3 | -5.68 Million USD | 2.15% |
| 2011 Q4 | -5.65 Million USD | 0.53% |
| 2011 FY | -23.02 Million USD | 0.88% |
| 2010 FY | -23.22 Million USD | -0.78% |
| 2010 Q3 | -5.86 Million USD | -2.29% |
| 2010 Q1 | -5.98 Million USD | -3.92% |
| 2010 Q2 | -5.72 Million USD | 4.33% |
| 2010 Q4 | -5.64 Million USD | 3.62% |
| 2009 FY | -23.04 Million USD | 0.29% |
| 2009 Q4 | -5.76 Million USD | -3.6% |
| 2009 Q1 | -5.74 Million USD | 76.32% |
| 2009 Q2 | -5.97 Million USD | -3.97% |
| 2009 Q3 | -5.56 Million USD | 6.91% |
| 2008 Q3 | -6.22 Million USD | -10.93% |
| 2008 Q4 | -24.26 Million USD | -290.16% |
| 2008 Q2 | -5.6 Million USD | -1.39% |
| 2008 Q1 | -5.53 Million USD | 70.91% |
| 2008 FY | -23.11 Million USD | -26.86% |
| 2007 FY | -18.21 Million USD | -174.16% |
| 2007 Q3 | -5.51 Million USD | -13.97% |
| 2007 Q2 | -4.83 Million USD | -43.21% |
| 2007 Q1 | -3.37 Million USD | 47.31% |
| 2007 Q4 | -19.01 Million USD | -244.75% |
| 2006 Q1 | 950.94 Thousand USD | 49.51% |
| 2006 Q2 | -429.76 Thousand USD | -145.19% |
| 2006 Q3 | -2.41 Million USD | -462.86% |
| 2006 Q4 | -6.41 Million USD | -165.1% |
| 2006 FY | -6.64 Million USD | -107.7% |
| 2005 Q2 | 807.46 Thousand USD | 15.12% |
| 2005 Q1 | 701.41 Thousand USD | -23.72% |
| 2005 FY | -3.19 Million USD | -82.99% |
| 2005 Q4 | 636.05 Thousand USD | 0.0% |
| 2005 Q3 | 636.05 Thousand USD | -21.23% |
| 2004 Q1 | 919.55 Thousand USD | 0.0% |
| 2004 FY | -1.74 Million USD | -173.36% |
| 2004 Q2 | 919.55 Thousand USD | 0.0% |
| 2004 Q4 | 919.55 Thousand USD | 0.0% |
| 2004 Q3 | 919.55 Thousand USD | 0.0% |
| 2003 FY | 2.38 Million USD | 19.82% |
| 2002 FY | 1.98 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 182.43 Million USD | 100.126% |
| Muliang Viagoo Technology, Inc. | 3.3 Million USD | 106.963% |
| N2OFF, Inc. | 208.26 Thousand USD | 210.435% |
| Arcadia Biosciences, Inc. | 2.03 Million USD | 111.33% |